Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07324577

Effectiveness of Virtual Reality in Managing Anxiety for Patients Undergoing Radiotherapy for Prostate, Breast, Lung, or Head and Neck Cancer

Led by Wake Forest University Health Sciences · Updated on 2026-05-22

54

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

W

Wake Forest University Health Sciences

Lead Sponsor

A

Atrium Health Wake Forest Baptist

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating how virtual reality (VR) may help manage anxiety during radiation therapy for patients with prostate, breast, lung, or head and neck cancer. This randomized controlled trial aims to assess the feasibility, acceptability, tolerability, and initial clinical effects of using a VR headset during treatment sessions. The study is sponsored by Wake Forest University Health Sciences and focuses on comparing VR use with standard care during radiotherapy. Participants will be randomly assigned in a 2:1 ratio to either wear a VR headset (Meta Quest 2) during their radiation therapy or receive the standard radiation treatment without VR. Radiation therapists will also share their experiences using the VR device. Treatment sessions and device use will be monitored throughout the radiation course. Participants will undergo assessments before and after their first radiation treatment, every sixth treatment, and at the end of their therapy. These evaluations include measuring VR device use and functionality, anxiety changes using standardized tools, and acceptability of VR implementation. The study involves multiple visits aligned with the radiation schedule and will continue data collection until the end of the treatment period.

CONDITIONS

Brief Title

Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Planned for radiation therapy with 15 or more treatments using energies of 10 MV or less for prostate, breast, lung, or head and neck cancer
  • Age 18 years or older at consent
  • ECOG performance status of 0 to 3 at enrollment
  • Able to understand and willing to sign informed consent directly
Not Eligible

You will not qualify if you...

  • Previous radiation therapy
  • VR device interferes with radiation dosage during simulation or planning
  • Primary brain tumors, brain metastases, or cancer involving sinuses, orbits, nose, or ears
  • Uncontrolled illnesses or psychiatric conditions limiting study compliance
  • Known epilepsy, significant motion sickness, severe uncorrected vision or hearing impairments, or seizures
  • Skin defects, infections, or open wounds on face, scalp, or eyes where VR device is applied
  • Presence of pacemakers, internal defibrillators, hearing aids, or other implanted medical devices
  • Radiation therapists who have not treated at least one participant using the VR device

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Duration of radiation therapy (15 or more treatments)

Participants undergo radiation therapy with or without wearing the VR headset during treatment sessions to manage anxiety.

Assessments before and after the first radiation treatment, every 6th radiation treatment, and at the end of treatment

Follow-up

Duration - Up to 36 months

Participants are monitored for anxiety and acceptability of VR intervention after completing radiation therapy.

1 visit at 36 months

Trial Site Locations

Total: 1 location

1

Atrium Health Wake Forest Baptist Hayworth Cancer Center

High Point, North Carolina, United States, 27262

Actively Recruiting

Loading map...

Research Team

S

Sheri Whittington

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

3

Similar Trials

Use of 18F-Fluciclovine PET to Identify Tumors in Patients W...

Brain Metastasis

Actively Recruiting

1 location

Linking From an Artificial-Intelligence Driven Assessment of...

Virtual Reality

Actively Recruiting

1 location

ACTIVATE: A Pilot Randomized Activity Coaching Trial to Incr...

Radiation Therapy

Actively Recruiting

4 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here